Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
出版年份 2021 全文链接
标题
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
作者
关键词
-
出版物
DRUG DISCOVERY TODAY
Volume 27, Issue 2, Pages 436-455
出版商
Elsevier BV
发表日期
2021-10-08
DOI
10.1016/j.drudis.2021.09.020
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer
- (2021) Yu Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
- (2021) Milad Ashrafizadeh et al. CARBOHYDRATE POLYMERS
- Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance
- (2021) Yaseen Hussain et al. Cancers
- Long non-coding RNAs in the doxorubicin resistance of cancer cells
- (2021) Saeed Ashrafizaveh et al. CANCER LETTERS
- Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
- (2021) Sepideh Mirzaei et al. LIFE SCIENCES
- Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
- (2021) Sepideh Mirzaei et al. LIFE SCIENCES
- Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
- (2021) Milad Ashrafizadeh et al. LIFE SCIENCES
- Reversal of P‑Glycoprotein-Mediated Multidrug Resistance by Novel Curcumin Analogues in Paclitaxel-resistant Human Breast Cancer Cells
- (2020) Lei Gao et al. Biochemistry and Cell Biology
- Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer
- (2020) Ruda Lee et al. BIOCONJUGATE CHEMISTRY
- Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling
- (2020) Kang‐Yun Lee et al. CANCER SCIENCE
- Doxorubicin Encapsulated in TPGS‐Modified 2D‐Nanodisks Overcomes Multidrug Resistance
- (2020) Tingting Jiang et al. CHEMISTRY-A EUROPEAN JOURNAL
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico Study
- (2020) Di Sotto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells
- (2020) Su-Wei Xu et al. PHARMACOLOGICAL RESEARCH
- Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas
- (2020) Ke Jiang et al. OncoTargets and Therapy
- Effect simultaneous delivery with P-glycoprotein inhibitor and nanoparticle administration of doxorubicin on cellular uptake and in vitro anticancer activity
- (2020) Ozgur Esim et al. SAUDI PHARMACEUTICAL JOURNAL
- Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression
- (2020) Yue Yang et al. Biomed Research International
- The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
- (2020) Zhaolin Chen et al. Molecular Therapy-Nucleic Acids
- Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
- (2020) Ke Lin et al. Frontiers in Oncology
- Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
- (2020) Gamal-Eldein Fathy Abd-Ellatef et al. Pharmaceutics
- LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22
- (2020) Kewei Zhu et al. Aging-US
- Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
- (2020) He-Wen Wang et al. Aging-US
- Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin
- (2020) Jin Zhong et al. BIOCHEMICAL PHARMACOLOGY
- The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
- (2020) Jin Liu et al. BIOSCIENCE REPORTS
- Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
- (2020) Renxin Yi et al. BIOSCIENCE REPORTS
- The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a
- (2020) Dong Han et al. CIRCULATION RESEARCH
- Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance
- (2020) Xu Cheng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
- (2020) Muhammad Muzamil Khan et al. International Journal of Nanomedicine
- Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes
- (2020) Zhuo Chen et al. JOURNAL OF CONTROLLED RELEASE
- Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles
- (2020) Shuo Liu et al. MOLECULAR PHARMACEUTICS
- Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells
- (2020) Elisabetta Teodori et al. MOLECULES
- Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells
- (2020) Olga Wesołowska et al. MOLECULES
- Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats
- (2020) Jie Pan et al. XENOBIOTICA
- Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
- (2020) Cinzia Calcabrini et al. Frontiers in Pharmacology
- Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
- (2020) Edina Karai et al. Cancers
- Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
- (2020) Ying Chen et al. Frontiers in Oncology
- Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases
- (2020) Yu Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin
- (2020) Marina Sagnou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells
- (2020) Xiaoxin Shi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4
- (2020) Surbhi Chouhan et al. JOURNAL OF BIOSCIENCES
- Versatile role of curcumin and its derivatives in lung cancer therapy
- (2020) Milad Ashrafizadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hypocrellin B triggered sonodynamic therapy reverses multidrug resistance of doxorubicin-resistant SGC7901/ADR cells via down-regulation of P-gp expression
- (2020) Yichen Liu et al. JOURNAL OF CHEMOTHERAPY
- Overexpression of P‐glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients
- (2020) Mariam Ammar et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Co-delivery of doxorubicin and α-PCNA aptamer using AS1411-modified pH-responsive nanoparticles for cancer synergistic therapy
- (2020) Seyed Mohammad Taghdisi et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance
- (2020) Shinji Goto et al. Stem Cells International
- In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells
- (2020) Mohamed A. Morsy et al. PeerJ
- Lipid/Hyaluronic Acid–Coated Doxorubicin-Fe3O4 as a Dual-Targeting Nanoparticle for Enhanced Cancer Therapy
- (2020) Jinying Liang et al. AAPS PHARMSCITECH
- Porous Pt nanoparticles loaded with doxorubicin to enable synergistic Chemo-/Electrodynamic Therapy
- (2020) Tong Chen et al. BIOMATERIALS
- LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p
- (2020) Baiqi Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Dextran methacrylate hydrogel microneedles loaded with doxorubicin and trametinib for continuous transdermal administration of melanoma
- (2020) Shanghui Huang et al. CARBOHYDRATE POLYMERS
- Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery
- (2020) Xin Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- New insights into the activities and toxicities of the old anticancer drug doxorubicin
- (2020) Sabina Y. van der Zanden et al. FEBS Journal
- Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
- (2020) Hang Zhang et al. MEDICINAL RESEARCH REVIEWS
- LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis
- (2020) Yongxian Cao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Curcumin induces chemosensitization to doxorubicin in Duke’s type B coloadenocarcinoma cell line
- (2020) Jeyan Jayarajan et al. MOLECULAR BIOLOGY REPORTS
- Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers
- (2020) Milad Ashrafizadeh et al. PHARMACOLOGICAL RESEARCH
- Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P‑glycoprotein and MRPs expression
- (2020) Hongchun Guo et al. Oncology Letters
- Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
- (2020) Milad Ashrafizadeh et al. ACS Combinatorial Science
- Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System
- (2020) Tao Yu et al. Frontiers in Pharmacology
- GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
- (2020) Laurence Booth et al. Frontiers in Oncology
- Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
- (2020) Xiaozhong Liao et al. Frontiers in Oncology
- Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
- (2020) Monserrat Llaguno-Munive et al. Frontiers in Oncology
- P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers
- (2020) Anna Seelig Frontiers in Oncology
- PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P‐glycoprotein‐mediated multidrug resistance
- (2020) Rajeshkumar Anbazhagan et al. BIOTECHNOLOGY AND BIOENGINEERING
- Hyaluronic acid wreathed, trio-stimuli receptive and on-demand triggerable nanoconstruct for anchored combinatorial cancer therapy
- (2020) Kishwor Poudel et al. CARBOHYDRATE POLYMERS
- One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells
- (2020) Marialessandra Contino et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Plant extracts and betulin from Ligaria cuneifolia inhibit P-glycoprotein function in leukemia cells
- (2020) Jerónimo Laiolo et al. FOOD AND CHEMICAL TOXICOLOGY
- Doxorubicin-loaded composite nanogels for cancer treatment
- (2020) Marzieh Mohammadi et al. JOURNAL OF CONTROLLED RELEASE
- Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
- (2020) Jiun-I Lai et al. Frontiers in Oncology
- Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
- (2020) Wei Cui et al. Frontiers in Cell and Developmental Biology
- Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells
- (2020) Yuanwei Pan et al. JOURNAL OF CONTROLLED RELEASE
- miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer
- (2020) Hui Zhang et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer
- (2019) Sara G Creemers et al. ENDOCRINE-RELATED CANCER
- Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein
- (2019) Huaiming Wang et al. MEDICAL SCIENCE MONITOR
- Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
- (2019) Zhu Wang et al. Chinese Medicine
- Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells
- (2019) Yueling Yuan et al. International Journal of Nanomedicine
- The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells
- (2019) Kamila Środa-Pomianek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Doxorubicin and Adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer
- (2019) Qiong Wang et al. Acta Biomaterialia
- ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide
- (2019) Bo Jiang et al. DNA AND CELL BIOLOGY
- An updated patent review on P-glycoprotein inhibitors (2011-2018)
- (2019) Marcello Leopoldo et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
- (2019) Mengchun Chen et al. International Journal of Nanomedicine
- Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment
- (2019) Ying Li et al. MOLECULAR PHARMACEUTICS
- Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer
- (2019) Aichen Cao et al. MOLECULAR PHARMACEUTICS
- Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer
- (2019) Kun Li et al. PHYTOTHERAPY RESEARCH
- Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway
- (2019) Hong Cai et al. PHYTOTHERAPY RESEARCH
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium
- (2019) Huaxiao Yang et al. ACS Nano
- FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
- (2019) Xin Zhang et al. CELL DEATH AND DIFFERENTIATION
- Ascorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion
- (2019) Yutong Liu et al. FREE RADICAL RESEARCH
- MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
- (2019) Shun-Zhen Zheng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells
- (2019) Mutta Kairuki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts
- (2019) Elena Gazzano et al. CANCER LETTERS
- MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53
- (2019) Wei Wang et al. CANCER LETTERS
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- 3-benzazecine-based cyclic allene derivatives as highly potent P-glycoprotein inhibitors overcoming doxorubicin multidrug resistance
- (2019) Alexander A Titov et al. Future Medicinal Chemistry
- Molecular Energetics of Doxorubicin Pumping by Human P-Glycoprotein
- (2019) Lijie Wang et al. Journal of Chemical Information and Modeling
- Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques
- (2019) Youkyung H Choi et al. JOURNAL OF INFECTIOUS DISEASES
- Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance
- (2019) Aaron Goldman et al. Science Signaling
- Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis
- (2019) Hongyao Du et al. ACS Applied Materials & Interfaces
- Aptamer-Based Erythrocyte-Derived Mimic Vesicles Loaded with siRNA and Doxorubicin for the Targeted Treatment of Multidrug-Resistant Tumors
- (2019) Tengfei Wang et al. ACS Applied Materials & Interfaces
- β‐ LAP achone ameliorates doxorubicin‐induced cardiotoxicity via regulating autophagy and Nrf2 signalling pathways in mice
- (2019) Saeed Nazari Soltan Ahmad et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Pioglitazone, an agonist of PPARγ, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression
- (2019) Takashi Higuchi et al. BIOMEDICINE & PHARMACOTHERAPY
- pH-sensitive amphiphilic chitosan-quercetin conjugate for intracellular delivery of doxorubicin enhancement
- (2019) Yuzhi Mu et al. CARBOHYDRATE POLYMERS
- A lncRNA coordinates with Ezh2 to inhibit HIF-1α transcription and suppress cancer cell adaption to hypoxia
- (2019) Xingwen Wang et al. ONCOGENE
- Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway
- (2019) Yonggang Zhang et al. OncoTargets and Therapy
- Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway
- (2019) Rui Wang et al. OncoTargets and Therapy
- Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance
- (2019) Hamdan S Al-malky et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes
- (2019) Xiaoxue Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- pH sensitive doxorubicin-loaded nanoparticle based on Radix pseudostellariae protein-polysaccharide conjugate and its improvement on HepG2 cellular uptake of doxorubicin
- (2019) Xixi Cai et al. FOOD AND CHEMICAL TOXICOLOGY
- VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling
- (2019) Xiangbin Tan et al. ONCOLOGY RESEARCH
- Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line
- (2019) W. Chen et al. VETERINARY JOURNAL
- Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
- (2019) Cedric Magaway et al. Cells
- Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors
- (2018) Xiao Wei et al. ACS Applied Materials & Interfaces
- Au Nanocage-Strengthened Dissolving Microneedles for Chemo-Photothermal Combined Therapy of Superficial Skin Tumors
- (2018) Liyun Dong et al. ACS Applied Materials & Interfaces
- Photoresponsive Nanovehicle for Two Independent Wavelength Light-Triggered Sequential Release of P-gp shRNA and Doxorubicin To Optimize and Enhance Synergistic Therapy of Multidrug-Resistant Cancer
- (2018) Ming Wu et al. ACS Applied Materials & Interfaces
- Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition
- (2018) Hassiba Rouibah et al. Anti-Cancer Agents in Medicinal Chemistry
- Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles
- (2018) Niyaz Ahmad et al. Chemistry Central Journal
- Recent Advances in the Development of Indazole-based Anticancer Agents
- (2018) Jinyun Dong et al. ChemMedChem
- Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review
- (2018) Mohammad Mohajeri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- Synthesis and biological evaluation of 2,5-disubstituted furan derivatives as P-glycoprotein inhibitors for Doxorubicin resistance in MCF-7/ADR cell
- (2018) Ya-Sheng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
- (2018) Wenjing Huang et al. International Journal of Nanomedicine
- Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors
- (2018) Elena Gazzano et al. JOURNAL OF CONTROLLED RELEASE
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice
- (2018) Tae Kim et al. MOLECULES
- Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin
- (2018) Hanmei Li et al. MOLECULES
- Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors
- (2018) Milan Hano et al. MOLECULES
- Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis
- (2018) Guo-Xin Hou et al. Cell Death & Disease
- Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery
- (2018) Ming Wu et al. Biomaterials Science
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Whole Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naive, High-Risk Prostate Cancer
- (2018) Weerachai Jaratlerdsiri et al. CANCER RESEARCH
- Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy
- (2018) Jian Fang et al. International Journal of Nanomedicine
- Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor
- (2018) Xiao Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Microneedle‐Array Patch Fabricated with Enzyme‐Free Polymeric Components Capable of On‐Demand Insulin Delivery
- (2018) Siyuan Chen et al. ADVANCED FUNCTIONAL MATERIALS
- Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma
- (2018) Ilaria Buondonno et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream
- (2018) Jin-Wook Kang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells
- (2018) Li Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K/Akt/NF-κB signaling pathway
- (2018) Ganesan Muthusamy et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Structural and functional aspects of P-glycoprotein and its inhibitors
- (2018) Shirin Mollazadeh et al. LIFE SCIENCES
- Co-delivery nanoparticles of doxorubicin and chloroquine for improving the anti-cancer effect in vitro
- (2018) Jia-Hui Sun et al. NANOTECHNOLOGY
- A call to arms: Unifying the fight against resistance
- (2018) Alexis Kaushansky et al. Science Signaling
- Cell and fluid sampling microneedle patches for monitoring skin-resident immunity
- (2018) Anasuya Mandal et al. Science Translational Medicine
- Biodegradable Gelatin Methacryloyl Microneedles for Transdermal Drug Delivery
- (2018) Zhimin Luo et al. Advanced Healthcare Materials
- The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo
- (2018) Yan Wen et al. Acta Pharmaceutica Sinica B
- Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
- (2018) Daniel de Klerk et al. Cancers
- Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation
- (2017) Jia Wang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Guggulsterone sensitized drug-resistant human hepatocarcinoma cells to doxorubicin through a Cox-2/P-gp dependent pathway
- (2017) Hong-Bin Xu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells
- (2017) Tassarut Chaisit et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor
- (2017) Chao Feng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer
- (2017) Chunlai Feng et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Oxidative Stress Promotes Doxorubicin-Induced Pgp and BCRP Expression in Colon Cancer Cells Under Hypoxic Conditions
- (2017) Martha L. Pinzón-Daza et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
- (2017) András Füredi et al. JOURNAL OF CONTROLLED RELEASE
- Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin
- (2017) Li Qin et al. JOURNAL OF DRUG TARGETING
- Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
- (2017) Deepali Waghray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selection and optimization of nano-formulation of P-glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells
- (2017) Tapan K. Dash et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Drug resistance reversal by combretastatin-A4 phosphate loaded with doxorubicin in polymersomes independent of angiogenesis effect
- (2017) Jinfang Zhu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
- (2017) Attila Hunyadi et al. MOLECULES
- Erratum: Cancer metabolism: a therapeutic perspective
- (2017) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation
- (2017) Zong-Lin Zhang et al. Breast Cancer
- PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
- (2017) Shengwei Liu et al. Oncotarget
- Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
- (2017) Dapeng Wu et al. Oncotarget
- 7-ketocholesterol and 27-hydroxycholesterol decreased doxorubicin sensitivity in breast cancer cells: estrogenic activity and mTOR pathway
- (2017) Chun-Wei Wang et al. Oncotarget
- Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells
- (2017) Yan Wen et al. Oncotarget
- Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
- (2017) Benny Zhitomirsky et al. Oncotarget
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin
- (2017) Shengpeng Wang et al. Scientific Reports
- Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer
- (2017) Yue Pan et al. Journal of Cancer
- Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress
- (2017) Amara Maryam et al. Scientific Reports
- Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer
- (2016) Zhen-zhen Pan et al. ACTA PHARMACOLOGICA SINICA
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres
- (2016) In-geun Ryoo et al. Biomolecules & Therapeutics
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
- (2016) Yang Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models
- (2016) Mariana S. Oliveira et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity
- (2016) Lothar Esser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer
- (2016) Li Lv et al. Journal of Biomedical Nanotechnology
- A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery
- (2016) Yuling Bao et al. JOURNAL OF CONTROLLED RELEASE
- Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells
- (2016) Aili Suo et al. Materials Science & Engineering C-Materials for Biological Applications
- Salvianolic acid B reverses multidrug resistance in HCT-8/VCR human colorectal cancer cells by increasing ROS levels
- (2016) Piaoting Guo et al. Molecular Medicine Reports
- Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
- (2016) Chao Wang et al. NANO LETTERS
- Osthole shows the potential to overcome P-glycoprotein-mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway
- (2016) HONG WANG et al. ONCOLOGY REPORTS
- Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer
- (2016) Anita K. Bakrania et al. PHARMACOLOGICAL RESEARCH
- Decursin inAngelica gigasNakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression
- (2016) Hyeong Sim Choi et al. PHYTOTHERAPY RESEARCH
- Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin
- (2016) Chaojun Xue et al. TUMOR BIOLOGY
- Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
- (2016) Yu-Lun Chen et al. CELLULAR ONCOLOGY
- Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors
- (2016) Joanna Kopecka et al. Oncotarget
- Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma
- (2016) Yuan-Zheng Xia et al. Oncotarget
- Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells
- (2016) Lei Zhang et al. Oncotarget
- Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer
- (2016) Li Lv et al. Oncotarget
- Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy
- (2016) Chun-ge Zhang et al. Scientific Reports
- Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
- (2016) Yuan Zhao et al. Scientific Reports
- Serum Pleiotrophin Could Be an Early Indicator for Diagnosis and Prognosis of Non-Small Cell Lung Cancer
- (2015) Zi-Yan Du et al. Asian Pacific Journal of Cancer Prevention
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro
- (2015) Mona Alibolandi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane
- (2015) Ornella Fantappiè et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
- (2015) Renata Silva et al. PHARMACOLOGY & THERAPEUTICS
- Mechanism of Ascorbate-Induced Cell Death in Human Pancreatic Cancer Cells: Role of Bcl-2, Beclin 1 and Autophagy
- (2015) Masayuki Fukui et al. PLANTA MEDICA
- Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas
- (2015) Lei Zhang et al. Science Signaling
- Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
- (2015) Aaron Goldman et al. Nature Communications
- Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas
- (2015) Lei Zhang et al. Science Signaling
- Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein
- (2015) Paul Szewczyk et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
- (2015) Benny Zhitomirsky et al. Oncotarget
- Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity
- (2014) Jie Tang et al. DRUG DELIVERY
- Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism
- (2014) Barbara Döring et al. DRUG METABOLISM REVIEWS
- The folate receptor as a rational therapeutic target for personalized cancer treatment
- (2014) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Metformin, cancer and glucose metabolism
- (2014) Barbara Salani et al. ENDOCRINE-RELATED CANCER
- Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy
- (2014) Cong Luo et al. JOURNAL OF CONTROLLED RELEASE
- Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells
- (2014) LAURA RONCUZZI et al. ONCOLOGY REPORTS
- Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein
- (2014) Hong-Bin Xu et al. PHYTOMEDICINE
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review
- (2013) Ping Ma et al. Nano Today
- The maths behind combination therapy
- (2013) Rebecca Kirk Nature Reviews Clinical Oncology
- Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain
- (2013) A. B. Ward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Refined structures of mouse P-glycoprotein
- (2013) Jingzhi Li et al. PROTEIN SCIENCE
- Pleiotrophin promotes perineural invasion in pancreatic cancer
- (2013) Jun Yao WORLD JOURNAL OF GASTROENTEROLOGY
- Pharmaceutical nanotechnology for oral delivery of anticancer drugs
- (2012) Lin Mei et al. ADVANCED DRUG DELIVERY REVIEWS
- Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress
- (2012) Julien Verrax et al. Anti-Cancer Agents in Medicinal Chemistry
- PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma
- (2012) Hideki Makinoshima et al. BMC CANCER
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1
- (2012) Jean-Pierre Gillet et al. DRUG RESISTANCE UPDATES
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
- (2012) Suneet Shukla et al. DRUG RESISTANCE UPDATES
- Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans
- (2012) Mi Sun Jin et al. NATURE
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression
- (2011) Cai-Guo Ye et al. CANCER LETTERS
- Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer
- (2011) Ying Kong et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- A Gene Optimization Strategy that Enhances Production of Fully Functional P-Glycoprotein in Pichia pastoris
- (2011) Jiangping Bai et al. PLoS One
- Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells
- (2010) Zhenyu Ding et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
- Qinghaosu (Artemisinin): The Price of Success
- (2008) N. J. White SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started